ArticleHepatology international2018

Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment.

Tomomi Okubo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.